Narayana Hrudayalaya Q2 FY26 Financial Highlights & Operational Review

Narayana Hrudayalaya (NH) has delivered a robust performance for the second quarter of FY26, achieving its highest-ever quarterly consolidated revenue and profitability. Key Financial Performance (Consolidated, YoY) Net Profit (PAT): Grew 30% YoY to ₹258 crore. Revenue from Operations: Increased 20% YoY to ₹1,644 crore. EBITDA: Rose 30% YoY to ₹403 crore. EBITDA Margin: Showed significant expansion, reaching 24.5% compared to 22.6% in the corresponding quarter last year (Q2 FY25). Segmental Revenue & Growth Drivers 1. India Operations: Revenue: ₹1,234.7 crore (an 8.8% YoY increase). Key Drivers: Performance was underpinned by a healthy increase in domestic patient footfall, an improved payor mix, and growing traction from the company's outreach clinics. This segment achieved its best-ever profitability margins. 2. Cayman Islands Operations: Revenue: ₹431.6 crore (an exceptional 78% YoY growth). Key Drivers: This segment was a primary growth catalyst, recording its highest-ever quarterly revenue. Growth was led by strong performance in both the tertiary care hospital and the related health insurance businesses. Balance Sheet & Financial Health The company maintains a strong and healthy balance sheet. Net Debt: Stood at ₹246.6 crore. Net Debt-to-Equity Ratio: Remained minimal at 0.06, indicating low leverage and a strong financial position. Key Operational & Clinical Enhancements (Q2 FY26) NH continues to focus on upgrading its clinical capabilities and service offerings: Howrah: Successfully installed an advanced dual-source 256-slice CT scanner and achieved a significant milestone, crossing 1,000 robotic surgeries. Bengaluru (Cardiac Sciences): Reported its highest-ever quarterly procedures, including 197 robotic and 420 minimally invasive cardiac surgeries. Jaipur: Expanded its service portfolio by introducing Bone Marrow Transplant (BMT) services.